摘要
目的探讨应用他汀类药物后急性冠状动脉综合征(ACS)患者妊娠相关性血浆蛋白-A (PAPP-A)水平的变化。方法应用双抗夹心酶联免疫吸附法(EUSA)分别测定40例ACS应用他汀类药物前后、20例稳定型心绞痛(SA)及20例非冠心病患者血清PAPP-A水平。结果ACS患者血清PAPP-A浓度均明显高于SA组和非冠心病组患者。应用他汀类药物后ACS患者血清PAPP-A水平降低(均P<0.01)。结论PAPP-A浓度在ACS患者血中明显升高,为ACS易损斑块新的血清标志物。
Objective To investigate changes of the serum pregnancy-associated plasma protein-A ( PAPP- A ) level in the patients with acute coronary syndrome (ACS) after treatment with TATIN. Methods The serum PAPP-A was detected by ELISA in 40 ACS patients and 20 stable angina patients and 20 non-CAD patients. Results PAPP-A levels were significantly higher in patients with ACS than in patients with stable angina and non-CHD and were higher in patients with ACS after taking TATIN ( P 〈 0.01 ). CondusIon PAPP-A levels are elevated in ACS and it is a new candidate marker of ACS which can reflect the instability of coronary atheroselerotie plaque.
出处
《中国医药》
2007年第9期524-526,共3页
China Medicine